CJC-1295/Ipamorelin 10mg Peptides
Built for precise study and predictable performance, this dual-peptide blend supports disciplined research from preparation to data collection.
Our CJC-1295/Ipamorelin research peptide blend is a lab-ready, neutral (unflavored) preparation featuring two complementary growth hormone secretagogue analogs with a total strength of 10mg. Developed for controlled environments and careful handling, it is intended to help researchers evaluate receptor signaling, timing profiles, and protocol-dependent outcomes with clarity.
- CJC-1295 - A synthetic growth hormone-releasing hormone analog frequently evaluated for its capacity to support robust, pulse-oriented signaling dynamics in validated models.
- Ipamorelin - A selective ghrelin receptor agonist studied for targeted receptor engagement and a clean signaling profile in comparative in vitro and ex vivo assays.
In practice, this non-edible peptide blend is selected for studies requiring orderly preparation, methodical reconstitution, and repeatable administration parameters. Researchers commonly emphasize solvent selection, pH, and temperature control to maintain integrity during solution prep and storage. The combination of CJC-1295 and Ipamorelin is often investigated for coordinated kinetics—enabling exploration of timed pulses, receptor specificity, and downstream pathway characterization under tightly defined protocols.
Peptide Scientific Labs is a USA-based source focused on consistency, reliability, and the disciplined handling of sensitive materials. Our processes prioritize careful sourcing, controlled environments, and analytical checkpoints designed to support identity, purity, and lot-to-lot continuity. Documentation is maintained for transparency, and batches are routinely assessed to align with stringent internal specifications before release to the research community.
For laboratory research use only. Not for human consumption, medical use, or veterinary use. Handle using appropriate protective equipment and follow standard laboratory safety practices, including proper storage, labeling, and disposal procedures. By choosing Peptide Scientific Labs, you’re selecting a research partner committed to quality standards that are non-negotiable, so your team can focus on methods, measurements, and meaningful results.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is CJC/IPA Blend typically studied for?
This blend is usually studied for pulsatile growth-hormone release, GH/IGF-1 signaling, and recovery-oriented experimental protocols. A good FAQ should also make clear that the exact behavior of the blend depends on whether the CJC component is DAC or non-DAC, since that changes duration and pulse pattern.
What is CJC/IPA Blend?
CJC/IPA Blend combines a GHRH analog such as CJC-1295 with Ipamorelin, a ghrelin-receptor agonist. The blend is meant to bring together two different upstream pathways involved in endogenous growth-hormone signaling. For site content, it should be described as a research blend used in endocrine and recovery-related studies.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
This Product Contains
